Stay updated on Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Some links or labels for additional multiple myeloma information from MedlinePlus were removed from the study record’s resource links.
    Difference
    0.1%
    Check dated 2026-11-14T14:29:34.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A banner announcing NIH updates and FAQs about using “Super Intelligence” alongside “Artificial Intelligence” was removed. The study record content remains unchanged.
    Difference
    1%
    Check dated 2026-11-07T14:12:35.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site revision in the footer changed from v3.7.2 to v3.8.0, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T14:46:00.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A banner was added above the ClinicalTrials.gov navigation announcing NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T17:09:56.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.2 instead of v3.7.1 on the forbidden-access page.
    Difference
    0.2%
    Check dated 2026-10-17T16:59:04.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page; no study details are shown.
    Difference
    0.2%
    Check dated 2026-10-10T17:47:40.000Z thumbnail image

Stay in the know with updates to Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Adds to VRd in Multiple Myeloma Clinical Trial page.